News Headlines Article

FDA releases transparency policy report
Modern Healthcare

The Food and Drug Administration has implemented the second phase of an ongoing transparency initiative with the release of a public-disclosure policy report. The report contains draft proposals for 21 specific actions aimed at providing clinicians, healthcare-product manufacturers and the public with better insight into the FDA’s decision-making process, according to an executive summary issued by the transparency task force.